Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
North east receives its first life sized childbirth simulators
A major sea rescue mission sees a man saved at Hendon. It is thought he had been fishing from the promenade.
New Metro fares in 2016 will mean a rise in the cost of daysavers, and a reduction in single fares